Development of novel small molecule antiviral therapeutics for pathogens with epidemic potential
In short
This is a Research and Innovation Action under Horizon Europe. The budget is €44.2 million for about 5 grants of €9 million to €11 million each. Deadline: 17 February 2027.
What the call wants to achieve
- The scientific and clinical communities have a better understanding of and access to experimental antivirals for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation.
- Candidate antiviral therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic.
Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0, summarised. The official call text and its annexes decide eligibility, budget and deadlines.
Similar calls
17 Febin 106 days
Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses
Open
17 Febin 106 days
Development of monoclonal antibodies to prevent and treat infections from Flaviviruses
Open
17 Febin 106 days
Tools and technologies to support health adaptation to climate change
Open
17 Febin 106 days
Integrating climate-related exposures into the human exposome and characterising its changes in response to climate change
Open
17 Febin 106 days
Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Open